| 1 |
Neumann EK, Comi TJ, Rubakhin SS, et al. Lipid heterogeneity between astrocytes and neurons revealed by single-cell MALDI-MS combined with immunocytochemical classification [J]. Angew Chem Int Ed Engl, 2019, 58(18): 5910-5914.
|
| 2 |
Choi C, Finlay DK. Diverse immunoregulatory roles of oxysterols-the oxidized cholesterol metabolites [J]. Metabolites, 2020, 10(10): 384.
|
| 3 |
He Y, Xie K, Yang K, et al. Unraveling the interplay between metabolism and neurodevelopment in health and disease [J]. CNS Neurosci Ther, 2025, 31(5): e70427.
|
| 4 |
Petrov AM, Kasimov MR, Zefirov AL. Brain cholesterol metabolism and its defects: linkage to neurodegenerative diseases and synaptic dysfunction [J]. Acta Naturae, 2016, 8(1): 58-73.
|
| 5 |
Ren B, Burkovetskaya M, Jung Y, et al. Dysregulated cholesterol metabolism, aberrant excitability and altered cell cycle of astrocytes in fragile X syndrome [J]. Glia, 2023, 71(5): 1176-1196.
|
| 6 |
Chattopadhyay A, Sharma A. Smith-Lemli-Opitz syndrome: a pathophysiological manifestation of the bloch hypothesis [J]. Front Mol Biosci, 2023, 10: 1120373.
|
| 7 |
Kiyoshi C, Tedeschi A. Axon growth and synaptic function: a balancing act for axonal regeneration and neuronal circuit formation in CNS trauma and disease [J]. Dev Neurobiol, 2020, 80(7-8): 277-301.
|
| 8 |
Liemisa B, Newbury SF, Novy MJ, et al. Brain apolipoprotein E levels in mice challenged by a Western diet increase in an allele-dependent manner [J]. Aging Brain, 2023, 4: 100102.
|
| 9 |
Boyles JK, Pitas RE, Wilson E, et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system [J]. J Clin Invest, 1985, 76(4): 1501-1513.
|
| 10 |
Tarr PT, Edwards PA. ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2 [J]. J Lipid Res, 2008, 49(1): 169-182.
|
| 11 |
Moulton MJ, Barish S, Ralhan I, et al. Neuronal ROS-induced glial lipid droplet formation is altered by loss of Alzheimer's disease-associated genes [J]. Proc Natl Acad Sci U S A, 2021, 118(52): e2112095118.
|
| 12 |
Borrell-Pages M, Luquero A, Vilahur G, et al. Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function [J].Cardiovasc Res, 2023, 120(2): 140-151.
|
| 13 |
Yu C, Youmans KL, LaDu MJ. Proposed mechanism for lipoprotein remodelling in the brain [J]. Biochim Biophys Acta, 2010, 1801(8): 819-823.
|
| 14 |
Herz J, Bock HH. Lipoprotein receptors in the nervous system [J]. Annu Rev Biochem, 2002, 71: 405-434.
|
| 15 |
Bogdanovic N, Bretillon L, Lund EG, et al. On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells [J]. Neurosci Lett, 2001, 314(1-2): 45-48.
|
| 16 |
Peake KB, Vance JE. Normalization of cholesterol homeostasis by 2-hydroxypropyl-β-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice [J]. J Biol Chem, 2012, 287(12): 9290-9298.
|
| 17 |
Dai L, Wang J, Meng L, et al. The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson's disease [J]. PLoS Biol, 2025, 23(2): e3002974.
|
| 18 |
Ioannou MS, Jackson J, Sheu SH, et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity [J]. Cell, 2019, 177(6): 1522-1535. e14.
|
| 19 |
Schönfeld P, Reiser G. Brain energy metabolism spurns fatty acids as fuel due to their inherent mitotoxicity and potential capacity to unleash neurodegeneration [J]. Neurochem Int, 2017, 109: 68-77.
|
| 20 |
Wat LW, Chao C, Bartlett R, et al. A role for triglyceride lipase brummer in the regulation of sex differences in Drosophila fat storage and breakdown [J]. PLoS Biol, 2020, 18(1): e3000595.
|
| 21 |
Kim WS, Weickert CS, Garner B. Role of ATP-binding cassette transporters in brain lipid transport and neurological disease [J]. J Neurochem, 2008, 104(5): 1145-1166.
|
| 22 |
Corales LG, Inada H, Owada Y, et al. Fatty acid preference for beta-oxidation in mitochondria of murine cultured astrocytes [J]. Genes Cells, 2024, 29(9): 757-768.
|
| 23 |
Chen J, Li Q, Wang J. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions [J]. Proc Natl Acad Sci U S A, 2011, 108(36): 14813-14818.
|
| 24 |
Belaidi AA, Bush AI, Ayton S. Apolipoprotein E in Alzheimer's disease: molecular insights and therapeutic opportunities [J]. Mol Neurodegener, 2025, 20(1): 47.
|
| 25 |
Qi G, Mi Y, Shi X, et al. ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism [J]. Cell Rep, 2021, 34(1): 108572.
|
| 26 |
Lanfranco MF, Ng CA, Rebeck GW. ApoE lipidation as a therapeutic target in Alzheimer's disease [J]. Int J Mol Sci, 2020, 21(17): 6336.
|
| 27 |
Farmer BC, Kluemper J, Johnson LA. Apolipoprotein E4 alters astrocyte fatty acid metabolism and lipid droplet formation [J]. Cells, 2019, 8(2): 182.
|
| 28 |
Lindner K, Gavin AC. Isoform- and cell-state-specific ApoE homeostasis and function [J]. Neural Regen Res, 2024, 19(11): 2456-2466.
|
| 29 |
Zalocusky KA, Najm R, Taubes AL, et al. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease [J]. Nat Neurosci, 2021, 24(6): 786-798.
|
| 30 |
Nelson TJ, Sen A. Apolipoprotein E particle size is increased in Alzheimer's disease [J]. Alzheimers Dement (Amst), 2019, 11: 10-18.
|
| 31 |
Vecchio FL, Bisceglia P, Imbimbo BP, et al. Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease? [J]. Ther Adv Chronic Dis, 2022, 13: 20406223221081605.
|
| 32 |
Singh SK, Kordula T, Spiegel S. Neuronal contact upregulates astrocytic sphingosine-1-phosphate receptor 1 to coordinate astrocyte-neuron cross communication [J]. Glia, 2022, 70(4): 712-727.
|
| 33 |
Chen J, Stork T, Kang Y, et al. Astrocyte growth is driven by the Tre1/S1pr1 phospholipid-binding G protein-coupled receptor [J]. Neuron, 2024, 112(1): 93-112. e10.
|
| 34 |
Alam S, Afsar SY, van Echten-Deckert G. S1P released by SGPL1-deficient astrocytes enhances astrocytic ATP production via S1PR(2,4), thus keeping autophagy in check: potential consequences for brain health [J]. Int J Mol Sci, 2023, 24(5): 4581.
|
| 35 |
Mishra A, Gordon GR, MacVicar BA, et al. Astrocyte regulation of cerebral blood flow in health and disease [J]. Cold Spring Harb Perspect Biol, 2024, 16(4): a041354.
|
| 36 |
Clasadonte J, Poulain P, Hanchate NK, et al. Prostaglandin E2 release from astrocytes triggers gonadotropin-releasing hormone (GnRH) neuron firing via EP2 receptor activation [J]. Proc Natl Acad Sci U S A, 2011, 108(38): 16104-16109.
|
| 37 |
Paniagua-Herranz L, Gil-Redondo JC, Queipo MJ, et al. Prostaglandin E2 impairs P2Y2/P2Y4 receptor signaling in cerebellar astrocytes via EP3 receptors [J]. Front Pharmacol, 2017, 8: 937.
|
| 38 |
Zhang Y, Chen K, Sloan SA, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex [J]. J Neurosci, 2014, 34(36): 11929-11947.
|
| 39 |
Harkany T, Tretiakov E, Varela L, et al. Molecularly stratified hypothalamic astrocytes are cellular foci for obesity [J]. Res Sq, 2024: rs.3.rs-3748581.
|
| 40 |
Chen ZP, Wang S, Zhao X, et al. Lipid-accumulated reactive astrocytes promote disease progression in epilepsy [J]. Nat Neurosci, 2023, 26(4): 542-554.
|
| 41 |
Chen WT, Lu A, Craessaerts K, et al. Spatial transcriptomics and in situ sequencing to study Alzheimer's disease [J]. Cell, 2020, 182(4): 976-991. e19.
|
| 42 |
Zucha D, Abaffy P, Kirdajova D, et al. Spatiotemporal transcriptomic map of glial cell response in a mouse model of acute brain ischemia [J]. Proc Natl Acad Sci U S A, 2024, 121(46): e2404203121.
|
| 43 |
Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies [J]. Cell, 2019, 179(2): 312-339.
|
| 44 |
Zhang Y, Chen H, Li R, et al. Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future [J]. Signal Transduct Target Ther, 2023, 8(1): 248.
|
| 45 |
Matveyenka M, Ali A, Mitchell CL, et al. Cholesterol accelerates aggregation of α-synuclein simultaneously increasing the toxicity of amyloid fibrils [J]. ACS Chem Neurosci, 2024, 15(21): 4075-4081.
|
| 46 |
Wang H, Kulas JA, Wang C, et al. Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol [J]. Proc Natl Acad Sci U S A, 2021, 118(33): e2102191118.
|
| 47 |
Wang C, Shou Y, Pan J, et al. The relationship between cholesterol level and Alzheimer's disease-associated APP proteolysis/Aβ metabolism [J]. Nutr Neurosci, 2019, 22(7): 453-463.
|
| 48 |
Hashemi M, Banerjee S, Lyubchenko YL. Free cholesterol accelerates Aβ self-assembly on membranes at physiological concentration [J]. Int J Mol Sci, 2022, 23(5): 2803.
|
| 49 |
Mi Y, Qi G, Vitali F, et al. Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration [J]. Nat Metab, 2023, 5(3): 445-465.
|
| 50 |
Staurenghi E, Giannelli S, Testa G, et al. Cholesterol dysmetabolism in Alzheimer's disease: a starring role for astrocytes? [J]. Antioxidants (Basel), 2021, 10(12): 1890.
|
| 51 |
Sun H, Yang T, Simon RP, et al. Role of cholesterol metabolic enzyme CYP46A1 and its metabolite 24S-hydroxycholesterol in ischemic stroke [J]. Stroke, 2024, 55(10): 2492-2501.
|
| 52 |
叶一, 曾勇. 血脂与轻度认知障碍相关性的研究进展 [J/OL]. 中华脑血管病杂志(电子版), 2024, 18(1): 14-18.
|
| 53 |
Prajapat M, Kaur G, Choudhary G, et al. A systematic review for the development of Alzheimer's disease in in vitro models: a focus on different inducing agents [J]. Front Aging Neurosci, 2023, 15: 1296919.
|
| 54 |
Wang T, Zhang X, Wang Y, et al. High cholesterol and 27-hydroxycholesterol contribute to phosphorylation of tau protein by impairing autophagy causing learning and memory impairment in C57BL/6J mice [J]. J Nutr Biochem, 2022, 106: 109016.
|
| 55 |
Tuck BJ, Miller LVC, Katsinelos T, et al. Cholesterol determines the cytosolic entry and seeded aggregation of tau [J]. Cell Rep, 2022, 39(5): 110776.
|
| 56 |
van der Kant R, Langness VF, Herrera CM, et al. Cholesterol metabolism is a druggable axis that independently regulates Tau and amyloid-β in iPSC-derived Alzheimer's disease neurons [J]. Cell Stem Cell, 2019, 24(3): 363-375. e369.
|
| 57 |
Bryleva EY, Rogers MA, Chang CCY, et al. ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD [J]. Proc Nat Acad Sci U S A, 2010, 107(7): 3081-3086.
|
| 58 |
Feringa FM, van der Kant R. Cholesterol and Alzheimer's disease; from risk genes to pathological effects [J]. Front Aging Neurosci, 2021, 13: 690372.
|
| 59 |
Raulin AC, Doss SV, Trottier ZA, et al. ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies [J]. Mol Neurodegener, 2022, 17(1): 72.
|
| 60 |
Dias D, Portugal CC, Relvas J, et al. From genetics to neuroinflammation: the impact of ApoE4 on microglial function in Alzheimer's disease [J]. Cells, 2025, 14(4): 243.
|
| 61 |
Mahley RW, Huang Y. Apolipoprotein e sets the stage: response to injury triggers neuropathology [J]. Neuron, 2012, 76(5): 871-885.
|
| 62 |
Wang C, Najm R, Xu Q, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector [J]. Nat Med, 2018, 24(5): 647-657.
|
| 63 |
Zhao J, Fu Y, Yamazaki Y, et al. ApoE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids [J]. Nat Commun, 2020, 11(1): 5540.
|
| 64 |
Litvinchuk A, Suh JH, Guo JL, et al. Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist [J]. Neuron, 2024, 112(3): 384-403. e8.
|
| 65 |
Liu L, Li Z, Zhou H, et al. Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update [J]. Stroke Vasc Neurol, 2023, 8(6): e3.
|
| 66 |
Collyer E, Blanco-Suarez E. Astrocytes in stroke-induced neurodegeneration: a timeline [J]. Front Mol Med, 2023, 3: 1240862.
|
| 67 |
乔红梅, 张京芬, 王宝军. 乳酸与乳酸化在缺血性卒中中的作用机制和研究进展 [J/OL]. 中华脑血管病杂志(电子版), 2025, 19(4): 274-279.
|
| 68 |
Kato T, Yoshioka H, Owada Y, et al. Roles of fatty acid binding protein 7 in ischemic neuronal injury and ischemia-induced neurogenesis after transient forebrain ischemia [J]. Brain Res, 2020, 1736: 146795.
|
| 69 |
Eraso-Pichot A, Brasó-Vives M, Golbano A, et al. GSEA of mouse and human mitochondriomes reveals fatty acid oxidation in astrocytes [J]. Glia, 2018, 66(8): 1724-1735.
|
| 70 |
Sayre NL, Sifuentes M, Holstein D, et al. Stimulation of astrocyte fatty acid oxidation by thyroid hormone is protective against ischemic stroke-induced damage [J]. J Cereb Blood Flow Metab, 2017, 37(2): 514-527.
|
| 71 |
Holstein DM, Saliba A, Lozano D, et al. β-hydroxybutyrate enhances brain metabolism in normoglycemia and hyperglycemia, providing cerebroprotection in a mouse stroke model [J]. J Cereb Blood Flow Metab, 2025, 45(8): 1493-1506.
|
| 72 |
Calabresi P, Di Lazzaro G, Marino G, et al. Advances in understanding the function of alpha-synuclein: implications for Parkinson's disease [J]. Brain, 2023, 146(9): 3587-3597.
|
| 73 |
Brekk OR, Honey JR, Lee S, et al. Cell type-specific lipid storage changes in Parkinson's disease patient brains are recapitulated by experimental glycolipid disturbance [J]. Proc Natl Acad Sci U S A, 2020, 117(44): 27646-27654.
|
| 74 |
Matveyenka M, Zhaliazka K, Kurouski D. Unsaturated fatty acids uniquely alter aggregation rate of α-synuclein and insulin and change the secondary structure and toxicity of amyloid aggregates formed in their presence [J]. FASEB J, 2023, 37(7): e22972.
|
| 75 |
Girard V, Jollivet F, Knittelfelder O, et al. Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson's disease [J]. PLoS Genet, 2021, 17(11): e1009921.
|
| 76 |
Ralhan I, Chang CL, Lippincott-Schwartz J, et al. Lipid droplets in the nervous system [J]. J Cell Biol, 2021, 220(7): e202102136.
|
| 77 |
Dai L, Wang J, Zhang X, et al. 27-hydroxycholesterol drives the spread of α-synuclein pathology in Parkinson's disease [J]. Mov Disord, 2023, 38(11): 2005-2018.
|
| 78 |
Huang XX, Li L, Jiang RH, et al. Lipidomic analysis identifies long-chain acylcarnitine as a target for ischemic stroke [J]. J Adv Res, 2024, 61: 133-149.
|
| 79 |
Walecha V, Luthra PM. The mitochondrial-astrocyte-neuron triad hypothesis in Parkinson's disease: a toxic feedback loop of metabolism, aggregation, and oxidative stress [J]. Neurochem Res, 2025, 50(5): 317.
|
| 80 |
Barik SK, Bansal R, Singh S. Targeting PI3K/Akt/mTOR with fisetin mechanistic and therapeutics insights for Parkinson's disease [J]. Lett Drug Des Discov, 2025, 22(12): 100319.
|
| 81 |
Du Y, Yang Y, Zhang C, et al. The spatiotemporal dynamic evolution of post-stroke neuroinflammation: energy metabolism mechanisms of acute response and chronic progression [J]. Front Pharmacol, 2026, 17: 1762764.
|
| 82 |
Yamazaki Y, Zhao N, Caulfield TR, et al. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies [J]. Nat Rev Neurol, 2019, 15(9): 501-518.
|
| 83 |
Chen Y, Jin H, Chen J, et al. The multifaceted roles of apolipoprotein E4 in Alzheimer's disease pathology and potential therapeutic strategies [J]. Cell Death Discov, 2025, 11(1): 312.
|
| 84 |
Honig LS, Barakos J, Dhadda S, et al. ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease [J]. Alzheimers Dement (N Y), 2023, 9(1): e12377.
|